On the 22nd of August 2022, was the first case of Monkeypox confirmed in Aruba. This is a resident with no recent travel history, for which DVG concluded that the contagion occurred on the island. A second case is still pending from the test results.
Monkeypox is transmitted from person to person through direct contact with blister fluid or blister wounds present on an infected person’s body, sometimes via an object on a surface used by an infected person or droplets that come out of the mouth, nose, or throat of the infected person. Symptoms that are also accompanied by Monkeypox are pain, headache, tiredness, swollen glands, and muscle pain.
DVG received the information that we will soon receive from RIVM in The Netherlands, a limited amount of vaccine to help protect against the Monkeypox virus. And the vaccine will be available for the largest risk group according to the instructions and management of The Netherlands. Through caregivers and specialists, citizens who fall within the risk group will be contacted to receive their vaccine if they want it.